Add to ORKGThe effect of prolonged administration of hydroxyurea on morbidity and mortality in adult patients with sickle cell syndromes: results of a 17-year, single-center tria
A randomized, controlled clinical trial established the efficacy and safety of short-term use of hyd...
Hydroxyurea has many characteristics of an ideal drug for sickle cell anemia (SCA) and provides ther...
sickle cell disease and stroke. Religious considerations pre-cluded transfusion and bone marrow tran...
The purpose of this evidence based practice literature review is to research the long term effects o...
Several controlled studies have evidenced good efficacy and short-term and mid-term safety profiles ...
A randomized, controlled clinical trial established the efficacy and safety of short-term use of hyd...
The efficacy of hydroxyurea (HU) and its role in the reduction in mortality in sickle cell patients ...
Hydroxyurea (HU) enhances the synthesis of fetal hemoglobin (HbF) and can improve the clinical cours...
In a published randomized clinical trial, hydroxyurea (HU) Improved clinical outcomes In patients wi...
Clinical experience with hydroxyurea for patients with sickle cell disease (SCD) has been accumulati...
We conducted the first nation-wide cohort study of sickle cell disease (SCD) in Italy, a Southern Eu...
The risks and benefits of long-term use of hydroxyurea in sickle cell anemia: A 17.5 year follow-up
Despite documented laboratory and clinical benefits of hydroxyurea for children with sickle cell ane...
Context: Hydroxyurea increases levels of fetal hemoglobin (HbF) and decreases morbidity from vaso-oc...
Despite documented laboratory and clinical benefits of hydroxyurea for children with sickle cell ane...
A randomized, controlled clinical trial established the efficacy and safety of short-term use of hyd...
Hydroxyurea has many characteristics of an ideal drug for sickle cell anemia (SCA) and provides ther...
sickle cell disease and stroke. Religious considerations pre-cluded transfusion and bone marrow tran...
The purpose of this evidence based practice literature review is to research the long term effects o...
Several controlled studies have evidenced good efficacy and short-term and mid-term safety profiles ...
A randomized, controlled clinical trial established the efficacy and safety of short-term use of hyd...
The efficacy of hydroxyurea (HU) and its role in the reduction in mortality in sickle cell patients ...
Hydroxyurea (HU) enhances the synthesis of fetal hemoglobin (HbF) and can improve the clinical cours...
In a published randomized clinical trial, hydroxyurea (HU) Improved clinical outcomes In patients wi...
Clinical experience with hydroxyurea for patients with sickle cell disease (SCD) has been accumulati...
We conducted the first nation-wide cohort study of sickle cell disease (SCD) in Italy, a Southern Eu...
The risks and benefits of long-term use of hydroxyurea in sickle cell anemia: A 17.5 year follow-up
Despite documented laboratory and clinical benefits of hydroxyurea for children with sickle cell ane...
Context: Hydroxyurea increases levels of fetal hemoglobin (HbF) and decreases morbidity from vaso-oc...
Despite documented laboratory and clinical benefits of hydroxyurea for children with sickle cell ane...
A randomized, controlled clinical trial established the efficacy and safety of short-term use of hyd...
Hydroxyurea has many characteristics of an ideal drug for sickle cell anemia (SCA) and provides ther...
sickle cell disease and stroke. Religious considerations pre-cluded transfusion and bone marrow tran...